| Code | Description | Claims | Bene. Records | Total Paid |
|---|
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
48 |
26 |
$1K |
| 88307 |
|
15 |
13 |
$723.94 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
138 |
134 |
$156.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
83 |
76 |
$98.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,720 |
1,165 |
$94.96 |
| 80053 |
Comprehensive metabolic panel |
1,202 |
885 |
$62.15 |
| 83735 |
|
177 |
81 |
$45.04 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
304 |
136 |
$42.66 |
| 82247 |
|
155 |
51 |
$37.98 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
43 |
41 |
$29.48 |
| 84484 |
|
247 |
172 |
$20.94 |
| 85027 |
|
141 |
75 |
$16.29 |
| 84100 |
|
57 |
27 |
$15.92 |
| 86901 |
|
340 |
315 |
$10.04 |
| 86900 |
|
328 |
289 |
$10.04 |
| 86880 |
|
55 |
55 |
$9.06 |
| 87430 |
|
35 |
34 |
$9.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
38 |
34 |
$8.16 |
| 81001 |
|
516 |
469 |
$7.31 |
| 81025 |
|
92 |
88 |
$7.00 |
| 84703 |
|
276 |
250 |
$6.32 |
| 83690 |
|
222 |
197 |
$5.79 |
| 82248 |
|
72 |
53 |
$4.22 |
| 85018 |
|
61 |
50 |
$1.99 |
| 85014 |
|
67 |
54 |
$1.99 |
| 81003 |
|
28 |
27 |
$1.89 |
| 84443 |
Thyroid stimulating hormone (TSH) |
74 |
66 |
$0.00 |
| 86592 |
|
50 |
49 |
$0.00 |
| 83605 |
|
79 |
41 |
$0.00 |
| 86850 |
|
97 |
93 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
67 |
59 |
$0.00 |
| 85730 |
|
52 |
48 |
$0.00 |
| 82962 |
|
910 |
120 |
$0.00 |
| 86140 |
|
25 |
14 |
$0.00 |
| 87340 |
|
150 |
147 |
$0.00 |
| 83880 |
|
38 |
28 |
$0.00 |
| 84132 |
|
15 |
12 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
106 |
105 |
$0.00 |
| 85379 |
|
14 |
14 |
$0.00 |
| 87420 |
|
32 |
32 |
$0.00 |
| 85610 |
|
90 |
70 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
53 |
50 |
$0.00 |
| 84702 |
|
41 |
35 |
$0.00 |
| 84550 |
|
29 |
12 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
75 |
74 |
$0.00 |
| 80061 |
Lipid panel |
17 |
15 |
$0.00 |
| 84145 |
|
17 |
14 |
$0.00 |